School of Medicine
Showing 351-400 of 490 Results
-
David Solow-Cordero
Associate Director, High-Throughput Screening, Innovative Medicines Accelerator (IMA)
Current Role at StanfordAssociate Director, High-Throughput Screening Knowledge Center, , Sarafan ChEM-H and Innovative Medicine Accelerator (IMA)
This high-throughput screening (HTS) laboratory allows Stanford researchers and others to discover novel modulators of targets that otherwise would not be practical in industry. The center incorporates instrumentation (purchased with NCRR NIH Instrumentation grant numbers S10RR019513, S10RR026338, S10OD025004, and S10OD026899), databases, compound libraries, and personnel whose previous sole domains were in industry.
Among our instrumentation are a fully automated Molecular Devices ImageXpress Micro Confocal High-Content fluorescence microplate imager, with live cell, fluidics and phase contrast options, an Echo 655 Acoustic Dispense, a Thermo integrated HTS robotic system, a Caliper Life Sciences SciClone ALH3000 and an Agilent Bravo microplate liquid handler, and the BMG Clariostarplus, Tecan Infinite M1000 and M1000 PRO and Molecular Devices FlexStation II 384 fluorescence, luminescence and absorbance multimode microplate readers.
We have over 180,000 small molecules for compound screens, 15,000 cDNAs for genomic screens, and whole genome siRNA libraries targeting the human genome (the siARRAY whole human genome siRNA library from Dharmacon, targeting 21,000 human genes) and the mouse genome (Qiagen mouse whole genome siRNA set V1 against 22,124 genes).
The HTSKC main screening lab is located in ChEM-H W008, the cell-based assay development lab is located in CCSR Room 0133-North Wing, between the Transgenic Mouse Facility, and the Stanford Genomics Facility. -
Ana Lilia Soto
Youth Development Manager, Psych/Public Mental Health & Population Sciences
Current Role at StanfordYouth Development Manager
-
Victoria "Vicki" Spencer
Program Coordinator, Pediatrics - Peds/Critical Care
BioA graduate of Purdue University, Vicki brings over 20 years of executive administrative support experience to her position at Stanford Medicine.
Prior to taking this role, Vicki supported the Chief Medical Officer and Chief Dental Officer for a group of Federally Qualified Health Centers (FQHC). She has also provided executive support to individuals in the field(s) of healthcare, food equity, and pre-clinical drug development.
Her passions are health equity and whole-system integrated care. -
Caleb Matthew Spiro
Temp CRCA, Psychiatry and Behavioral Sciences - Child & Adolescent Psychiatry and Child Development
BioMy main research interest revolves around understanding the general cognitive and affective properties of the mind, and how the prognosis of good and poor mental health status affects the developmental trajectories under chronic stress. To what extent reward-based networks can lead to increased proximity to vulnerability or heightened sensitivity to mental illness, specifically within the context of youth and adolescents, is an area that I am especially interested in. I am most interested in what factors help individuals become more resilient and build a narrative that they can get better with the right treatment practices. I believe that this can be done by combining neuroscience and functional imaging techniques (ex: fMRI, EEG) into the study and practice of clinical psychology.
-
Ryan Spitler
Deputy Director, Precision Health and Integrated Diagnostics and Canary Centers, Rad/Precision Health and Integrated Diagnostics
BioDr. Spitler is the Deputy Director of the Precision Health and Integrated Diagnostics Center at Stanford University. He completed his Post Doctorial Research Fellowship (SCIT) at Stanford University School of Medicine, conducting research in the developing field of Magnetogenetics for remote controlled cellular reprogramming and developed smart MRI cell tracking tools for oncology cell tracking studies. He has designed numerous biological models, synthetic biology approaches and worked on the development of new technologies in a number of scientific areas ranging from medical devices to gene therapy. Prior to his position at Stanford, Dr. Spitler received his Ph.D. in Cellular and Developmental Biology at the Beckman Laser Institute at the University of California, Irvine. His research at the Beckman Laser Institute included developing and characterizing new nitric oxide-based drugs, laser, and LED-based multimodal wound healing therapies some of which are currently being used in the clinic as a result of his work.
Dr. Spitler received his Bachelor’s of Science degree in Molecular Cell and Developmental Biology from the University of California, Santa Cruz, where he worked in the area of structural biology. Over the past two decades he has held a number of academic and industrial positions and has served as an advisor or advisory board member for a number of Bay Area companies. Dr. Spitler is the recipient of the Stanford Cancer Imaging Fellowship Training Award, RSL Innovation Challenge Award, the Biophotas Research Fellowship, and the Stanford Center for Biomedical Imaging Achievement Award. -
Suhas Srinivasan, Ph.D.
Principal Bioinformatics Scientist, Dermatology
BioI develop computational methods to discover insights at various resolutions of the biological hierarchy i.e., molecules, cells, tissues, organs, organism and population-scale.
In my current role, I lead the bioinformatics efforts for two groups that are pioneers in epigenomics research.
We study tissue development, cancer evolution, and autoimmunity using multiomics, with a focus on the non-coding genome.
I have over four years of professional experience in industry and academia, and over eight years of academic research experience.
I received my Ph.D. in Data Science specializing in machine learning development for diverse biomedical problems.
My research interests include artificial intelligence to identify novel patterns in multiomics data, psychometrics and neuroimaging data; structural bioinformatics and computational epidemiology. Additionally, I have conducted research in anomaly detection, and community detection in biological networks.
I am the co-inventor of a patented anomaly detection method for real-time streaming data.
